Sinclair Pharma Share Discussion Threads

[soundbuy] 10/5/2016 14:25

Drop the bid, catch a few off the order book, and back up.............

How long's it been...........zzzzzzzzzz

[soundbuy] 03/5/2016 10:41

Spot of fishing there early doors......

[steeplejack] 25/4/2016 17:52

Looks to me like Hargreave hold slightly less than 1.2% of equity on behalf of discretionary clients and have recently sold 40,000 shares at 34.55p

[eggbaconandbubble] 20/4/2016 12:23

What does that Hargreave Hale RNS signify? Anyone?

[scargs] 07/4/2016 20:04

eggbaconandbubble

You are so very quick off the mark!!!

It is good to see Schroders slowly building a stake in the company. This gives me confidence that this will be winner.

Scargs

[eggbaconandbubble] 07/4/2016 18:12

Schroders up to 5.868%.

Nah, nah, nee, nah, nah......beat you to it Scargs!!!!

[scargs] 06/4/2016 15:28

Schroders up to 5.864%.

As Dusty Springfield sang "little by little"!!!!!!!!!!!!!!

[scargs] 06/4/2016 07:59

Schroders up to 5.86%.

[scargs] 04/4/2016 15:37

Schroders now have 5.842%.

[soundbuy] 04/4/2016 07:45

Aye, nibbling away.

[scargs] 01/4/2016 17:04

Schroders now own 5.838% of Sinclair Pharma.

Interesting!!!!

[scargs] 31/3/2016 21:00

Schroders now own 5.82% of Sinclair Pharma.

Very encouraging.

[soundbuy] 30/3/2016 19:00

Offer period

[eggbaconandbubble] 30/3/2016 18:11

Can anyone explain why they are in this "offer period".
Does it stop hostile bids, restrain Tosca forcing the issue or what?
I've never come across this situation before, or certainly not for this length of time.
How long can it go on for?
Any comments welcome.

[soundbuy] 30/3/2016 12:13

Killik building a position (for clients?) too....

[soundbuy] 30/3/2016 12:08

Equity Development
$SPH Sinclair Pharma now 16 months into LSE "Offer Period", tho' clock effectively restarted in Dec '15 with Sale of non-Aesthetics business

Agreed - a different business with disposal and cash raised, reckon they're only 3 months max into talks re Aesthetics business, they inferred as much at disposal that they'd concentrated first on the non-Aesthetics side (if I remember correctly), leaves a clearer picture going fwd....will take a while (hence why no comment re advanced talks etc)....

One-off payment of EUR15.0 million in cash excellent too....

[steeplejack] 30/3/2016 11:19

Figures look ok and the third qtr is now as good as completed,so the improved sales performance is in the bag.Are we awaiting a takeover approach or an acquisition.I'm a bit puzzled.Hey ho.Chris Spooner, CEO, commented "Our decision to focus the business entirely on aesthetics has allowed us to build solid foundations to support future growth. We have built an exciting portfolio of high growth, differentiated products that address patient and physician demand for better, long-lasting natural results. The imminent US launch of Silhouette InstaLift(TM) will expose Sinclair to the world's largest aesthetics market and is expected to be transformational for both revenue and earnings growth. Underlying end-user sales growth remains strong, and as previously guided we have de-stocked our distribution channel reducing reported sales for the first half. The de-stocking process is largely complete and sales for the third quarter are expected to exceed first half sales. Our expectations for calendar 2016 and beyond remain unchanged and we are highly confident in the immediate and longer term outlook".

[scargs] 29/3/2016 15:48

After 12 noon today two separate purchases totalling 300,000 shares worth over £100,000.

These high value transactions are very welcome.

[scargs] 29/3/2016 15:36

Interim results up to 31/12/2015 out tomorrow.

Looking forward to reading them etc. Hopefully an update re the company's current prospects.

[shareinvestment] 29/3/2016 15:18

soundbuy, I'm only guessing here as no one knows what the future will look like. Nonetheless, I like very much the fact that the company has clearly stated in its accounts that they are focusing on the higher quality growth business and evaluating interest from third parties in this offer period and therefore worst case we are left with no debt and the growth business and plenty of cash in the bank. Furthermore they state: 'The Board will continue its assessment on how to maximize shareholder value and continues to receive attention with regards to the remaining aesthetics business from a number of international companies, many of which are interested in some form of co-operation, including co-promotion, licensing of products, repatriation of distribution agreements, development collaborations and merger and acquisition opportunities'.

[soundbuy] 29/3/2016 09:44

@shareinvestment


That's a cunning plan.....

[eggbaconandbubble] 27/3/2016 09:40

shareinvestment, are you suggesting that because of pressure by institutional shareholders they might sell everything in the near future and return all the proceeds to shareholders. Say, at a price totalling approx.60p as suggested by steeplejack?

[steeplejack] 25/3/2016 14:08

Very true.Tosca has a history of putting companies "into play".Yet the stockmarket is a strange animal nowadays.in the absence of prop book speculation(all but outlawed by regulation) thinly traded but tightly held stocks like SPH can move up and down for no meaningful reason.I suspect the stock could well be worth 60p plus to industry peers but the stockmarket valuation is happy to ignore as much.